GlassScriptPhysician profile
John R Harvey
NPI 1902893092
$5,241.11
in general payments reported to CMS, 2019-2025
10 companies · $44.25 in 2025
The $44.25 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $1,217 · 2021: $65.07 · 2022: $1,790 · 2023: $24.94 · 2024: $674 · 2025: $44.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512 · Travel and Lodging: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.57 |
| Travel and Lodging | $232.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,363.11 | 2021-2024 | |
| Medtronic Vascular, INC. | $2,055.10 | 2019-2020 | |
| Abbott Laboratories | $395.05 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $115.63 | 2019 | |
| Allergan, INC. | $115.57 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.00 | 2019 | |
| Abiomed | $44.25 | 2025 | |
| Innovation Technologies INC | $24.94 | 2023 | Irrisept |
| Astrazeneca Pharmaceuticals LP | $13.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.